Home>Topics>Companies>Stifel Nicolaus

Stifel Nicolaus SF

  1. All
  2. Commentary
  3. Stock Reports
  4. Headlines
    1. Trivascular Technologies IPO Could Be Less Than A Treat For Investors

      Headlines

      Tue, 15 Apr 2014

      Credit Suisse Securities (USA) LLC, J.P. Morgan Securities LLC Underwriters: Canaccord Genuity Inc, Stifel Nicolaus & Company Incorporated Summary of TRIV TRIV is a medical device company engaged in the development and commercialization

    2. Quiet Period Expiration For TriNet Group An Excellent Time To Buy Into Well-Backed Company

      Headlines

      Tue, 15 Apr 2014

      underwriters, including J.P. Morgan Securities LLC, Deutsche Bank Securities Inc, Morgan Stanley & Co LLC, Stifel Nicolaus & Company Inc, Jefferies LLC, and William Blair and Co LLC, will attempt to energize the stock with an infusion of

    3. No support for Tekmira yet

      Headlines

      Tue, 15 Apr 2014

      for RNA interference, some analysts remain bullish . RBC Capital has a $30 PT on the stock and Maxim Group has $31. Stifel Nicolaus is a bit more modest with $19. Most of the firm's 2013 revenue of $15.5M came from its contract with the DOD for

    4. What’s Abuzz About Gold?

      Headlines

      Tue, 8 Apr 2014

      of the Osisko deal, I find additional encouragement for the broader commodities space, as well as for gold, from Stifel Nicolaus ’ Barry Banister. His strategy for the second quarter of the year is that we may see a one-year rally in commodity-related

    5. Investors Could Sleep Well With La Quinta In Their Portfolios

      Headlines

      Tue, 8 Apr 2014

      Lebenthal & Co LLC, Loop Capital Markets LLC, Mischler Financial Group Inc, Raymond James and Associates Inc, RBC Capital Markets LLC, Samuel A. Ramirez & Company Inc, Stifel Nicolaus & Company Incorporated, Wells Complete Story »

    6. Analysis: Valuation on Nike attractive

      Headlines

      Tue, 8 Apr 2014

      Stifel Nicolaus upgrades Nike ( NKE ) to a Buy rating after finding valuation attractive with shares down almost 12% from their March highs. The investment firm sets a $87 price target on the stock. NKE +0.7% premarket Post your comment!

    7. IMS Health Holdings IPO Could Boost Shareholder Vitality

      Headlines

      Thu, 3 Apr 2014

      Securities Inc, Leerink Partners LLC, Mizuho Securities USA Inc, Piper Jaffray & Co, RBC Capital Markets LLC, Stifel Nicolaus & Company Incorporated, Suntrust Robinson Humphrey Inc, TPG Capital BD LLC, Wells Fargo Securities LLC, William Blair

    8. Analysis: Beam cut on valuation call

      Headlines

      Tue, 1 Apr 2014

      Stifel Nicolaus cuts its rating on Beam ( BEAM ) to Hold from Buy on a valuation call. Shares of BEAM are up 22.4% YTD. Post your comment!

    9. Everyday Health IPO Less Vigorous Than It Sounds

      Headlines

      Fri, 28 Mar 2014

      Underwriters: Citigroup Global Markets Inc, Credit Suisse Securities LLC, JP Morgan Securities LLC Underwriters: Stifel Nicolaus & Company Inc, Suntrust Robinson Humphrey Inc Summary EVDY uses data and analytics technology to provide its users with

    10. Conatus Pharmaceuticals' CEO Discusses Q4 2013 Results - Earnings Call Transcript

      Headlines

      Thu, 27 Mar 2014

      President and CEO Chuck Cashion - Senior Vice President and CFO Analysts Roy Buchanan - Piper Jaffray Stephen Willey - Stifel Nicolaus John Boris - SunTrust Bert Hazlett - ROTH Capital Presentation Operator Welcome to the Conatus Pharmaceuticals fourth quarter

    « Prev12345Next »
    Content Partners